Objective: The objective of this study is to estimate life expectancies of HIV-positive patients conditional on response to antiretroviral therapy (ART). Methods: Patients aged more than 20 years who started ART during 2000-2010 (excluding IDU) in HIV clinics contributing to the UK CHIC Study were followed for mortality until 2012.Wedetermined the latestCD4+ cell count and viral load before ART and in each of years 1-5 of ART. For each duration of ART, life tables based on estimated mortality rates by sex, age, latest CD4+ cell count and viral suppression (HIV-1 RN
Objectives: Life expectancy is an important indicator informing decision making in policies relating...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Background We sought to evaluate life expectancy and mortality of HIV-positive individuals initiatin...
Objective:The objective of this study is to estimate life expectancies of HIV-positive patients cond...
UK CHIC has been funded by the Medical Research Council (MRC), UK (Grant numbers G0000199, G0600337,...
Life expectancies (LEs) of patients in UK Collaborative HIV Cohort (UK CHIC) stratified by CD4 count...
Objectives: To estimate life expectancy for people with HIV undergoing treatment compared with life ...
Background: The life expectancy of people with HIV taking antiretroviral therapy (ART) has increased...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
SummaryBackgroundCombination antiretroviral therapy has led to significant increases in survival and...
PURPOSE OF REVIEW Improved virological and immunological outcomes and reduced toxicity of antiret...
We sought to evaluate life expectancy and mortality of HIV-positive individuals initiating combinati...
Objectives: Life expectancy is an important indicator informing decision making in policies relating...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Background We sought to evaluate life expectancy and mortality of HIV-positive individuals initiatin...
Objective:The objective of this study is to estimate life expectancies of HIV-positive patients cond...
UK CHIC has been funded by the Medical Research Council (MRC), UK (Grant numbers G0000199, G0600337,...
Life expectancies (LEs) of patients in UK Collaborative HIV Cohort (UK CHIC) stratified by CD4 count...
Objectives: To estimate life expectancy for people with HIV undergoing treatment compared with life ...
Background: The life expectancy of people with HIV taking antiretroviral therapy (ART) has increased...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
Writing committee: The Antiretroviral Therapy Cohort Collaboration (ART-CC)International audienceBac...
SummaryBackgroundCombination antiretroviral therapy has led to significant increases in survival and...
PURPOSE OF REVIEW Improved virological and immunological outcomes and reduced toxicity of antiret...
We sought to evaluate life expectancy and mortality of HIV-positive individuals initiating combinati...
Objectives: Life expectancy is an important indicator informing decision making in policies relating...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
Background We sought to evaluate life expectancy and mortality of HIV-positive individuals initiatin...